Cellular & Molecular Biology Letters

Papers
(The TQCC of Cellular & Molecular Biology Letters is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review214
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment184
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery147
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC133
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development111
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway75
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges70
lncRNA PVT1: a novel oncogene in multiple cancers55
Osteoporosis pathogenesis and treatment: existing and emerging avenues46
Melatonin and cancer suppression: insights into its effects on DNA methylation44
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo41
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L41
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress40
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration40
0.67436504364014